1D-LSD Announced: The New Legal Lysergamide & 1V-LSD Successor In Germany!
1D-LSD - It's official: our reptilian friends have done it again!
Update 28-05-24: 1D-LSD will be banned in Germany 1-2 weeks after the next Bundesrat meeting on June 14th 2024.
Given the small pieces of information we had previously heard from Lizard Labs, we are incredibly happy, surprised and relieved to announce that they have successfully synthesized a 1V-LSD successor: 1D-LSD.
This evening's newsletter from LL reads:
We are pleased to announce the release of our latest German-legal lysergamide, 1D-LSD. After many months of tinkering around in the lab and repeated failures during the R&D phase, we have now managed to produce the first few grams of compound.
They go on to say:
This is a massive win as we were convinced the German government had us in checkmate due to the scope of the recent NpSG amendment. We explored several candidates and 1D-LSD showed the most promising results in terms of its pharmacological profile.
Lizard Lab's first description of 1D-LSD's pharmacological profile is very exciting. They comment that:
Initial results from our test group indicate that 1D-LSD has a much faster onset and a slightly shorter duration compared to 1V-LSD, with the majority of researchers noting that 1D-LSD gave more consistent and reproducible results. Based on this promising feedback, we may even have a compound that is superior to 1P-LSD or 1cP-LSD in terms of its qualitative effects!
From a chemical perspective, the fast onset could be explained by the highly-strained 1,2-dimethylcyclobutane group which may enable quick metabolism and hydrolysis to LSD in-vivo. The potency of 1D-LSD appears to be about equal to 1V-LSD, we have therefore kept the standard blotter dose at 150mcg.
Some thoughts and hopes for the future: Is 1D-LSD qualitatively unique? Is this the end of the road?
The first descriptions of 1D-LSD are intriguing.
While it's inevitable each new lysergamide will be compared to the original LSD-25, we believe each compound should be evaluated and recognized in its own right. 1V-LSD had some unique qualities that gave it its distinct character. We hope 1D-LSD is similar in this regard.
We will carry out some of our own experiments ASAP so we can provide trip reports and more qualitative details.
What do you guys think of these developments? We were under the impression LL would be unable to find an alternative, and this was the end of the line for our German friends, but the cat-and-mouse game continues for now. With the German government shutting down 1V-LSD in record time, we can't help but assume 1D-LSD's days are already numbered.
The legacy of Valerie is an overwhelmingly positive one. She brought much beauty, insight, and wisdom to many thousands of people. It's a sad state of affairs that the German government continues to pursue outdated and authoritarian legislation to suppress compounds that bring so much value to the lives of their citizens.
Unfortunately, until it becomes politically untenable (or profitable for the right people), it is likely to be business as usual for the legislators and bureaucrats.
Public opinion on psychedelic medicines has changed much over the last few decades, so positive change does feel increasingly possible. If the United States is capable of doing a 360-degree turn and effectively legalizing cannabis after so many years of criminalization, perhaps anything is possible.
Public debate and discourse on these matters are extremely important. We want to provide a platform for such conversations to take place - for people to share and discuss their experiences openly and honestly. We will continue to build our blog as a place for you guys to interact with each other, share information and build a community. Reach out to David at [email protected] if you're interested in joining our writing team.